Healthcare

The US healthcare provider finds itself confronting the most severe challenges in its recent history. A disastrous earnings forecast, a...

Viking Therapeutics has captured significant market attention following the release of impressive clinical trial results for its obesity treatment candidate...

The pharmaceutical sector is witnessing unprecedented excitement around innovative obesity treatments, with Eli Lilly positioned squarely at the epicenter of...

Shares of animal health company Zoetis experienced a dramatic sell-off on November 4th, plummeting 13.78 percent to establish a new...

US health insurer Humana witnessed a dramatic sell-off in its stock after presenting mixed quarterly results and significantly revising its...

The independent public trading journey of Nevro has reached its conclusion. Effective April 3, 2025, the company's shares are no...

The financial stability of ModivCare appears increasingly fragile as the company navigates a complex Chapter 11 bankruptcy process. With a...

The publicly traded chapter of Asensus Surgical has concluded following its complete acquisition by the KARL STORZ Group. The company's...

Centene shares have endured a punishing period in the markets, plummeting over 40% year-to-date. However, the healthcare giant's latest quarterly...

The investment community is watching closely as Stereotaxis, a pioneer in robotic medical technology, prepares to release its quarterly earnings....